Formaldehyde as a potential human leukemogen: An assessment of biological plausibility

Critical Reviews in Toxicology

Volumn 36, Issue 2, 2006, Pages 135-153

  Golden, Robert ^a   Pyatt, David ^b,c   Shields, Peter G ^d  

^a ToxLogic   (United States)

^b LLP   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d GEORGETOWN UNIVERSITY   (United States)

Author keywords

Biological Plausibility; Formaldehyde; Leukemia; Leukemogenesis; Mode of Action

Indexed keywords

ALKYLATING AGENT; BENZENE; BIMOLANE; BUSULFAN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; EPIPODOPHYLLOTOXIN; ETOPOSIDE; FORMALDEHYDE; MELPHALAN; NITROSOUREA; PLACEBO; RAZOXANE; TENIPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE NONLYMPHOCYTIC LEUKEMIA; BLOOD TOXICITY; BONE MARROW APLASIA; BONE MARROW TOXICITY; CANCER; CANCER RISK; CANCER SURVIVAL; CHEMICAL CARCINOGENESIS; CHROMOSOME ABERRATION; CLINICAL TRIAL; CORRELATION ANALYSIS; DNA RECOMBINATION; DNA REPAIR; DNA REPLICATION; DRUG DOSE REGIMEN; DRUG INDICATION; DRUG INDUCED CANCER; EPIDEMIOLOGICAL DATA; ERYTHROLEUKEMIA; GAMMA RADIATION; GENOTOXICITY; HEMATOPOIETIC SYSTEM; HUMAN; INDUCED MUTATION; LEUKEMIA; LEUKEMOGENESIS; LUNG CARCINOMA; LYMPHATIC LEUKEMIA; MUTAGENICITY; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOMONOCYTIC LEUKEMIA; NONHODGKIN LYMPHOMA; NONHUMAN; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OVARY CANCER; PANCYTOPENIA; POLYCYTHEMIA VERA; PRELEUKEMIA; RADIATION CARCINOGENESIS; REVIEW; SISTER CHROMATID EXCHANGE; SMOKING; TARGET ORGAN; THROMBOCYTOPENIA;

ANIMALS; CARCINOGENS; FORMALDEHYDE; HUMANS; LEUKEMIA; MUTAGENS; RISK;

ANIMALIA;

EID: 33644974083     PISSN: 10408444     EISSN: 15476898     Source Type: Journal    
DOI: 10.1080/10408440500533208     Document Type: Review

References (146)

1. Abraham, N.G. (1996). Hematopoietic effects of benzene inhalation assessed by long-term bone marrow culture. Environ. Health Perspect. 104 Suppl 6: 1277-1282.
2. Agency for Toxic Substances and Disease Registry. (1999). Toxicological Profile for Formaldehyde. U.S. Department of Health and Human Services, Public Health Service, Washington, DC.
3. Aksoy, M. (1989). Hematotoxicity and carcinogenicity of benzene. Environ. Health Perspect. 82:193-197.
4. Anderson, M., Larson, R., Mauritzson, N., Schnittger, S., Jhanwar, S., and Pedersen-Bjergaard, J. (2002). Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: Report from an international workshop. Genes Chromosomes Cancer 33:395-400.
5. Appelman, L.M., Woutersen, R.A., and Zwart, A. (1988). One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J. Appl. Toxicol. 8:85-90.
6. Attia, S.M., Kliesch, U., Schriever-Schwemmer, G., Badary, O.A. Hamada, F.M., and Adler, I.D. (2003). Etoposide and merbarone are clastogenic and aneugenic in the mouse bone marrow micronucleus test complemented by fluorescence in situ hybridization with the mouse minor satellite DNA probe. Environ. Mol. Mutagen. 41(2):99-103.
7. Austin, H., and Cole, P. (1986). Cigarette smoking and leukemia. J. Chron. Disorders 39(6):417-421.
8. Bar-Sela, G., Tsalic, M., Gaitini, D., Steiner, M., and Haim, N. (2003). Paclitaxel, carboplatin, and oral etoposide in advanced gastric adenocarcinoma: Association with severe myelotoxicity. Med. Oncol. 20(3):291-294.
9. Bauchinger, M., and Schmid, E. (1985). Cytogenetic effects in lymphocytes of formaldehyde workers of a paper factory. Mutat. Res. 158:195-199.
10. Beaumont, M., Sanz, M., Carli, P.M., Maloisel, X., Thomas, L., and Fenaux, P. (2003). Therapy-related acute promyelocytic leukemia. J. Clin. Oncol. 21:2123-2137.
11. Berger, M.R., Habs, M., and Schmähl, D. (1985). Comparative carcinogenic activity of prednimustine, chlorambucil, prenisolone and chlorambucil plus prednisolone in Sprague-Dawley rats. Arch. Geschwulstforsch. 55:429-442.
12. Berk, P.D., Goldberg, J.D., Silverstein, M.N., Weinfeld, A., Donovan, P.B., Ellis, J.T., Landaw, S.A., Laszlo, J., Najean, Y., Pisciotta, A.V., and Wasserman, L.R. (1981). Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N. Engl. J. Med. 304:441-447.
13. Bonassi, S., Hagmar, L., Stromberg, U., Montagud, A.H., Tinnerberg, H., Forni, A., Heikkila, P., Wanders, S., Wilhardt, P., Hansteen, I.L., Knudsen, L.E., and Norppa H., (2000). Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60(6):1619-1625.
14. Bowen, D.T. (2000). Oxidative stress and the myelodysplastic syndromes. Leukocyte Res. 24:139-140.
15. Brownson, R.C. (1989). Cigarette smoking and risk of leukemia. J. Clin. Epidemiol. 42:1025-1026.
16. Brownson, R.C., Novotny, T.E., and Perry, M.C. (1993). Cigarette smoking and adult leukemia: A meta-analysis. Arch. Intern. Med. 153:469-475.
17. Brusamolino, E., Anselmo, A., Klersy, C., et al. (1998). The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher after combined modality programs than after chemotherapy alone and is correlated with the extent of radio therapy and type and duration of chemotherapy: A case control study. Haematologica 83:812-823.
18. Burkhart, K.K., Kulig, K.W., and McMartin K.E. (1990). Formate levels following a formalin ingestion. Vet. Hum. Toxicol. 32:135-137.
19. Casanova, M., and Heck, Hd'A. (1987). Further studies of the metabolic incorporation and covalent binding of inhaled [3H]- and [14C] formaldehyde in Fischer-344 rats: Effects of glutathione depletion. Toxicol. Appl. Pharmacol. 89:105-121.
20. Casanova, M., Heck, H. d'A., Everitt, J. I., Harrington, W. W., Jr., and Popp, J. A. (1988). Formaldehyde concentrations in the blood of rhesus monkeys after inhalation exposure. Food. Chem. Toxicol. 26:715-716.
21. Casanova, M., Heck, H. d'A., and Janszen, D. (1996). Comments on "DNA-protein crosslinks, a biomarker of exposure to formaldehyde - In vitro and in vivo studies" by Shaham et al. (letter to the Editor). Carcinogenesis 17:2097-2101.
22. 3H]formaldehyde. Toxicol. Appl. Pharmacol. 76:26-44.
23. Cascinu, S., Del Ferro, E., Ligi, M., Graziano, F., and Catalano, G. (1997). The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer. Am. J. Clin. Oncol. 20(5):477-478.
24. Choudhury, R.C., Palo, A.K., and Sahu, P. (2004). Cytogenetic risk assessment of etopiside from mouse bone marrow. J. Appl. Toxicol. 24(2):115-122.
25. Chu, J., Cao, S., Ying, H., and Li, D. (1981). Experimental study of busulfan-induced leukemia in strain 615 mice [Chin.]. Zhonghua Xueyexue Zazhi 2:10-13.
26. Cierniak, A., Papiez, M., and Kapiszewska, M. (2004). Modulatory effect of quercetin on DNA damage, induced by etoposide in bone marrow cells and on changes in the activity of antioxidant enzymes in rats. Rocz. Akad. Med. Bialymst. Supp 1:167-169.
27. Coggon, D., Harris, E.C., Poole, J., and Palmer, K.T. (2003). Extended follow-up of a cohort of british chemical workers exposed to formaldehyde. JNCI 95(21):1608-1615.
28. Cole, P., and Axten, C. (2004). Formaldehyde and leukemia: An improbable causal relationship. Regul. Toxicol. Pharmacol. 40(2):107-112.
29. Coltman, C.A., and Dahlberg, S. (1990). Treatment-related leukemia. N. Engl. J. Med. 322:52-53.
30. Conolly, R.B., Kimbell, J.S., Janszen, D., Schlosser, P.M., Kalisak, D., Preston, J., and Miller, F.J. (2004). Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol. Sci. 82(1):279-296.
31. Cronkite, E.P. (1986). Benzene hematotoxicity and leukemogenesis. Blood Cells 12:129-137.
32. Cronkite, E.P., Bullis, J.E., and Inoue, T. (1984). Benzene inhalation produces leukemia in mice. Toxicol. Appl. Pharmacol. 75:358-361.
33. Cronkite, E.P., Drew, R.T., and Inoue, T. (1985). Benzene hematotoxicity and leukemogenesis. Am. J. Ind. Med. 7:447-456.
34. Cronkite, E.P., Drew, R.T., and Inoue, T. (1989). Hematotoxicity and carcinogenicity of inhaled benzene. Environ. Health Perspect. 82:97-108.
35. Dallas, C.E., Mellard, D.N., Theiss, J.C., Pentecost, A.R., and Fairchild, E.J. 2nd. (1987). Distribution of DNA and RNA content in the bone marrow and alveolar macrophages of rats after subchronic inhalation of formaldehyde. Environ. Res. 43(1):191-202.
36. Dallas, C.E., Scott, M.J., Ward, J.B., Jr, and Theiss, J.C. (1992). Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats after repeated formaldehyde inhalation. J. Appl. Toxicol. 12:199-203.
37. Dean, J.H., Lauer, L.D., House, R.V., Murray, M.J., Stillman, W.S., Irons, R.D., Steinhagen, W.H., Phelps, M.C., and Adams, D.O. (1984). Studies of immune function and host resistance in B6C3F1 mice exposed to formaldehyde. Toxicol. Appl. Pharmacol. 72(3):519-529.
38. De Renzo, A., Santoro, L.F.E., Notaro, R., Pane, F., Buonaiuto, M.R., Luciano, L., and Rotoli, B. (1999). Acute promyelocytic leukemia after treatment for non-Hodgkin's lymphoma with drugs targeting topoisomerase II. Am. J. Hematol. 60:300-304
39. Dunn, C.D., and Elson, L.A. (1970). The comparative effect of busulphan ("Myleran") and aminochlorambucil on haemopoietic colony forming units in the rat. Cell Tissue Kinet. 3(2):131-141.
40. Eells, J.T., McMartin, K.E., and Black, K. (1981). Formaldehyde poisoning: Rapid metabolism to formic acid. J. Am. Med. Assoc. 246:1237-1238.
41. Faiola, B., Fuller, E.S., Wong, V.A., and Recio, L. (2004). Gene expression profile in bone marrow and hematopoietic stem cells in mice exposed to inhaled benzene. Mutat. Res. 549(1-2):195-212.
42. Farris, G.M., Robinson, S.N., Gaido, K.W., Wong, B.A., Wong, V.A., Leonard, L., and Shah, R. (1996). Effects of low concentrations of benzene on mouse hematopoietic cells in vivo: A preliminary report. Environ. Health Perspect. 104(Suppl 6):1275-1276.
43. Farris, G.M., Robinson, S.N., Gaido, K.W., Wong, B.A., Wong, V.A., Hahn, W.P., and Shah, R.S. (1997). Benzene-induced hematotoxicity and bone marrow compensation in B6C3F1 mice. Fundam. Appl. Toxicol. 36(2):119-129.
44. Feron, V.J., Til, H.P., and Woutersen, R.A. (1990). Formaldehyde in Sprague-Dawley rats. Toxicol. Ind. Health 6(6):637-639.
45. Feron, V.J., Til, H.P., de Vrijer, F., Woutersen, R.A., Cassee, F.R., and van Bladeren, P.J. (1991). Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259(3-4):363-385.
46. Franks, S.J. (2005). A mathematical model for the absorption and metabolism of formaldehyde vapour by humans. Toxicol. Appl. Pharmacol 206(3):309-320.
47. Freestone, J., and Bentley, A. (1989). Case of formaldehyde poisoning. Br. J. Pharm. Pract. 11:20-21.
48. Georgieva, A.V., Kimbell, J.S., and Schlosser, P.M. (2003). A distributed-parameter model for formaldehyde uptake and disposition in the rat nasal lining. Inhal. Toxicol. 15(14):1435-1463.
49. Greene, M.H., Harris, E.L., Gershenson, D.M., Malkasian, G.D., Jr, Melton, L.J., III, Dembo, A.J., Bennett, J.M., Moloney, W.C., and Boice, J.D., Jr. (1986). Melphalan may be a more potent leukemogen than cyclophosphamide. Ann. Intern. Med. 105:360-367.
50. Guest, I., and Uetrecht, J. (2000). Drugs toxic to the bone marrow that target the stromal cells. Immunopharmacology 46(2):103-112.
51. Haas, J.F., Kittelmann, B., Mehnert, W.H., Staneczek, W., Mohner, M., Kaldor, J.M., and Day, N.E. (1987). Risk of leukaemia in ovarian tumour and breast cancer patients following treatment by cyclophosphamide. Br. J. Cancer 55:213-218.
52. Hagmar, L., Bonassi, S., Stromberg, U., Brogger, A., Knudsen, L.E., Norppa, H., and Reuterwall, C. (1998a). Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH). Cancer Res. 58(18):4117-4121.
53. Hagmar, L., Bonassi, S., Stromberg, U., Mikoczy, Z., Lando, C., Hansteen, I.L., Montagud, A.H., Knudsen, L., Norppa, H., Reuterwall, C., Tinnerberg, H., Brogger, A., Forni, A., Hogstedt, B., Lambert, B., Mitelman, F., Nordenson, I., Salomaa, S., and Skerfving, S. (1998b). Cancer predictive value of cytogenetic markers used in occupational health surveillance programs: A report from an ongoing study by the European Study Group on Cytogenetic Biomarkers and Health. Mutat. Res. 405(2):171-178.
54. Hagmar, L., Stromberg, U., Tinnerberg, H., and Mikoczy, Z. (2001). The usefulness of cytogenetic biomarkers as intermediate end-points in carcinogenesis. Int. J. Hyg. Environ. Health 204(1):43-47.
55. Hagmar, L., Stromberg, U., Bonassi, S., Hansteen, I.L., Knudsen, L.E., Lindholm, C., and Norppa, H. (2004). Impact of types of lymphocyte chromosomal aberrations on human cancer risk: Results from Nordic and Italian cohorts. Cancer Res. 64(6):2258-2263.
56. Hauptmann, M., Lubin, LH., Stewart, P.A., Hayes, R.B., and Blair, A. (2003). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J. Nat. Cancer Inst. 95(21):1615-1623.
57. He, J.L., Jin, L.F., and Tin, H.Y. (1998). Detection of cytogenetic effects in peripheral lymphocytes of students exposed to formaldehyde with cytokinesis-blocked micronucleus assay. Biomed. Environ. Sci. 11:87-92.
58. Heath, C.W. (1990). Cigarette smoking and hematopoietic cancer. JNCI 82:1800-1801.
59. Heck, H., and Casanova, M. (2004). The implausibility of leukemia induction by formaldehyde: A critical review of the biological evidence on distant-site toxicity. Reg. Toxicol. Pharmacol. 40(2):92-106.
60. Heck, H.D., Casanova-Schmitz, M., Dodd, P.B., Schachter, E.N., Witek, T.J., and Tosun, T. (1985). Formaldehyde (CH2O) concentrations in the blood of humans and Fischer-344 rats exposed to CH2O under controlled conditions. Am. Ind. Hyg. Assoc. J. 46:1-3.
61. Hoffmann, L., Moller, P., Pedersen-Bjergaard, J., Wagge, A., Pedersen, M., and Hirsch, F.R. (1995). Therapy-related acute promyelocytic leukemia with t(15;17)(q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann. Oncol. 6:781-788.
62. Hsieh, L.L., Liou, S.H., Chiu, L.L., and Chen, Y.H. (1999). Glutathione S-transferase (GST) M1 and GST T1 genotypes and hematopoietic effects of benzene exposure. Arch. Toxicol. 73(2):80-82.
63. Huff, J.E., Haseman, J.K., and DeMarini, D.M. (1989). Multiple-site carcinogenicity of benzene in Fischer 344 rats and B6C3F mice. Environ. Health Perspect. 82:125-163.
64. Infante, P.F., Rinsky, R.A., and Wagoner, J.K. (1977). Leukemia in benzene workers. Lancet 2:76-78.
65. International Agency for Research on Cancer (IARC). (1974). Some aromatic amines, hydrazine and related substances, N-nitroso compounds and miscellaneous alkylating agents. IARC Monogr. Eval. Carcinogenic Risks to Humans. World Health Organization.
66. International Agency for Research on Cancer IARC. (1981). Some antineoplastic and immunosuppressive agents. IARC Monogr. Eval. Carcinogen. Risks Huma. 26.
67. International Agency for Research on Cancer. (1987). IARC monographs on the evaluation of carcinogenic risks to humans. Overall evaluations of carcinogenicity: An updating of IARC Monographs Volumes 1 to 42. Supp. 7. Lyon, France: World Health Organization, International Agency for Research on Cancer, pp. 38-74.
68. International Agency for Research on Cancer. (2000). X-radiation and gamma (γ)-radiation. IARC Monogr. Eval. Carcinogen. Risks Huma. 75.
69. International Agency for Research on Cancer. (2004). Formaldehyde, 2 butoxyethanol and 1-tert-butoxy-2-propanol. IARC Monogr. Eval. Carcinogen. Risks Huma. 82:2-9.
70. International Programme for Chemical Safety. (1999). Principles for the Assessment of Risks to Human Health from Exposure to Chemicals. Environmental Health Criteria No. 210. World Health Organization.
71. Irons, R.D., and Stillman, W.S. (1996a). The effects of benzene and other leukaemogenic agents on haematopoietic stem and progenitor cell differentiation. Eur. J. Haematol. Suppl. 60:119-124.
72. Irons, R.D. and Stillman, W.S. (1996b). The process of leukemogenesis. Environ. Health Perspect. 104(Suppl. 6):1239-1246.
73. Jagetia, G.C., and Aruna, R. (1999). Elevation of micronuclei frequency in mouse bone marrow treated with various doses of teniposide (VM-26). Toxicol Lett. 104(3):203-210.
74. Jandl, J.H. (1997). Blood, Textbook of Hematology. Little, Brown & Company, Boston.
75. Johannsen, F.R., Levinskas, G.J., and Tegeris, A.S. (1986). Effects of formaldehyde in the rat and dog following oral exposure. Toxicol. Lett. 30:1-6.
76. Kamata, E., Nakadate, M., and Uchida, O. (1997). Results of a 28-month chronic inhalation toxicity study of formaldehyde in male Fischer-344 rats. J. Toxicol. Sci. 22:239-254.
77. Kerns, W.D., Pavkov, K.L., and Donofrio, D.J. (1983b). Carcinogenic - ity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res. 43:4382-4391.
78. Kitaeva, L. V., Kitaev, E. M., and Pimenova, M. N. (1990). Cytopathic and cytogenetic effects of chronic inhalation of formaldehyde on germ and marrow cells of the female rat. Tsitologiia 32:1212-1216.
79. Koppel, C., Baudisch, H., and Schneider, V. (1990). Suicidal ingestion of formalin with fatal complications. Intens. Care Med. 16:212-214.
80. Korte, J.E., Hertz-Picciotto, I., Schulz, M.R., Ball, L.M., and Duell, E.J. (2000). The contribution of benzene to smoking-induced leukemia. Environ. Health Perspect. 108(4):333-339.
81. Leone, G., Mele, L., Pulsoni, A., Equitani, F., and Pagano, L. (1999). The incidence of secondary leukemias. Haematologica 84:937-945.
82. Lin, H., She, Y.,H., Cassileth, B.R., Sirotnak, F., and Cunningham Rundles, S. (2004). Maitake beta-glucan MD-fraction enhances bone marrow colony formation and reduces doxorubicin toxicity in vitro. Int. Immunopharmacol. 4(1):91-99.
83. Linet, M.S., Yin, S.N., Travis, L.B., Li, C.Y., Zhang, Z.N., Li, D.G., Rothman, N., Li, G.L., Chow, W.H., Donaldson, J., Dosemeci, M., Wacholder, S., Blot, W.J., Hayes, R.B., Wang, Y.Z., Dai, T.R., Chao, X.J., Qing, C., Jiang, Z.L., Zhang, W.U., Ye, P.Z., Kou, Q.R., Fan, Y.H., and Zhang, X.C. (1996). Clinical features of hematopoietic malignancies and related disorders among benzene-exposed workers in China. Environ. Health Perspect. 104(Suppl. 6):1353-1364.
84. Lohrmann, H.P., and Schreml, W. (1982). Cytotoxic drugs and the granulopoietic system. Recent Results Cancer Res. 81:1-222.
85. Ma, T.H., and Harris, M.M. (1988). Review of the genotoxicity of formaldehyde. Mutat. Res. 196(1):37-59.
86. Marsh, G.M., and Youk, A.O. (2004). Reevaluation of mortality risks from leukemia in the formaldehyde cohort study of the National Cancer Institute. Regul. Toxicol. Pharmacol. 40(2):113-124.
87. McLaughlin, J.K., Hrubec, Z., Linet, M.S., Heineman, E.F., Blot, W.J., Fraumeni, J.F. Jr. 1989. Cigarette smoking and leukemia. JNCI 81:1262-1263.
88. Medinsky, M.A., Kenyon, E.M., Seaton, M.J., and Schlosser, P.M. (1996). Mechanistic considerations in benzene physiological model development. Environ. Health Perspect. 104(Suppl. 6):1399-404.
89. Mondello, C., Giorgi, R., and Nuzzo, F. (1984). Chromosomal effects of methotrexate on cultured human lymphocytes. Mutat. Res. 139(2):67-70.
90. Morley, A., and Blake, J. (1974). An animal model of chronic aplastic marrow failure. I. Late marrow failure after busulfan. Blood 44:49-56.
91. Nakanomyo, H., Hiraoka, M. and Shiraya, M. (1986). Mutagenicity tests of etoposide and teniposide. J. Toxicol. Sci. Suppl. 1:301-10.
92. Natarajan, A.T., Darroudi, F. Bussman, C.J., and van Kesteren-van Leeuwen, A.C. (1983). Evaluation of the mutagenicity of formaldehyde in mammalian cytogenetic assays in vivo and vitro. Mutat. Res. 122(3-4):355-360.
93. National Toxicology Program. (1994). Seventh Annual Report on Carcinogens: 1994 Summary. National Toxicology Program. Benzene. U.S. DHHS, PHS, Washington, DC.
94. Nelson, N., Levine, R.J., Albert, R.E., Blair, A.E., Griesemer, R.A., Landrigan, P.J., Stayner, L.T., and Swenberg, J.A. (1986). Contribution of formaldehyde to respiratory cancer. Environ. Health Perspect. 70:23-35.
95. Niculescu, R., and Kalf, G.F. (1995). A morphological analysis of the short-term effects of benzene on the development of the hematological cells in the bone marrow of mice and the effects of interleukin-1 alpha on the process. Arch. Toxicol. 69(3):141-148.
96. Ochs, J., Rodman, J., Abromowitch, M., Kavanagh, R., Harris, M., Yalowich, J., and Rivera, G.K. (1991). A phase II study of combined methotrexate and teniposide infusions prior to reinduction therapy in relapsed childhood acute lymphoblastic leukemia: A Pediatric Oncology Group study. J. Clin. Oncol. 9(1):139-144.
97. Oredipe, O.A., Furbert-Harris, P.M., Laniyan, I., Green, W.R., Griffin, W.M., and Sridhar, R. (2003). Mice primed with swainsonine are protected against doxorubicin-induced lethality. Cell Mol. Biol. 49(7):1089-1099.
98. Park, D.J., and Koeffler, H.P. (1996). Therapy-related myelodysplastic syndromes. Semin. Hematol. 33:256-273.
99. Parke, D.V. (1996). Personal reflections on 50 years of study of benzene toxicology. Environ. Health Perspect. 104(Suppl. 6):1123-1128.
100. Pedersen-Bjergaard, J., Ersbøll, J., Sørensen, H.M., Keiding, N., Larsen, S.O., Philip, P., Larsen, M.S., Schultz, H., and Nissen, N.I. (1985). Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. Ann. Intern. Med. 103:195-200.
101. Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., and Nerlov, C. (2002). Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99(6):1909-1912.
102. Pereira, M.A., Chang, L.W., and McMillan, L. (1982). Battery of short-term tests in laboratory animals to corroborate the detection of human population exposures to genotoxic chemicals. [Abstract]. Environ. Mutagen. 4:317.
103. Petru, E., Berger, M.R., and Schmahl, D. (1989). Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence. Cancer Lett. 44(3):221-226.
104. Pinkerton, L.E., Hein, M.J., and Stayner, L.T. (2004). Mortality among a cohort of garment workers exposed to formaldehyde: An update. Occup. Environ. Med. 61(3):193-200.
105. Preston, R.J. and Hoffmann, G.R. (2001). Genetic toxicology. In: Casarett & Doull's Toxiclology: The Basic Science of Poisons, 6th ed., Klaassen, C.D., ed. McGraw-Hill, New York.
106. Pui, C.H., Ribeiro, R.C., et al. (1991). Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia. N. Engl. J. Med. 325:1682-1687.
107. Reimer, R.R., Hoover, R., Fraumeni, J.F., Jr, and Young, R.C. (1977). Acute leukemia after alkylating-agent therapy of ovarian cancer. N. Engl. J. Med. 297:177-181.
108. Schmahl, D., and Habs, M. (1978). Experimental carcinogenesis of antitumour drugs. Cancer Treat. Rev. 5(4):175-184.
109. Seidel, H.J., Barthel, E., and Zinser, D. (1989). The hematopoietic stem cell compartments in mice during and after long-term inhalation of three doses of benzene. Exp. Hematol. 17:300-303.
110. Severson, R.K., Davis, S., Heuser, L., Daling, J.R., and Thomas, D.B. (1990). Cigarette smoking and acute nonlymphocytic leukemia. Am. J. Epidemiol. 132:418-422.
111. Shaham, J., Bomstein, Y., Meltzer, A., Kaufman, Z., Palma, E., and Ribak, J. (1996). DNA-protein crosslinks, a biomarker of exposure to formaldehyde-in vitro and in vivo studies. Carcinogenesis 17:121-125.
112. Shaham, J., Gurvich, R., and Kaufman, Z. (2002). Sster chromatid exchange in pathology staff occupationally exposed to formaldehyde. Mutat. Res. 15:115-123.
113. Smit, E.F., Splinter, T.A., and Kok, T.C. (1992). A phase I study of daily oral teniposide for 20 days. Semin. Oncol. Suppl. 6:40-42.
114. Snyder, C.A., Goldstein, B.D., and Sellakumar, A.R. (1984). Evidence for hematotoxicity and tumorigenesis in rats exposed to 100 ppm benzene. Am. J. Ind. Med. 5:429-434.
115. Snyder, R. (2000). Recent developments in the understanding of benzene toxicity and leukemogenesis. Drug Chem. Toxicol. 23(1):13-25.
116. Snyder, R., and Hedli, C.C. (1996). An overview of benzene metabolism. Environ Health Perspect. 104(Suppl. 6):1165-1171.
117. Snyder, R., and Kalf, G.F. (1994). A perspective on benzene leukemogenesis. Crit. Rev. Toxicol. 24:177-209.
118. Soffritti, M., Maltoni, C., Maffei, R. and Biagi, R. (1989). Formaldehyde: An experimental multipotential carcinogen. Toxicol. Ind. Health 5(5):699-630.
119. Soffritti. M., Belpiggi, F., Lambertini, L., Lauriola, M., Padovani, M., and Maltoni, C. (2002). Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann. NY Acad. Sci. 982:87-105.
120. Stillman, W.S., Varella-Garcia, M., and Irons, R.D. (2000). The benzene metabolite, hydroquinone, selectively induces 5q31- and -7 in human CD34+CD19 - bone marrow cells. Exp. Hematol. 28(2):169-176.
121. Stoner, G.D., Shimkin, M.B., Kniazeff, A.J., Weisburger, J.H., Weisburger, E.K. and Gori, G.B. (1973). Test for carcinogenicity of food additives and chemotherapeutic agents by the pulmonary tumor response in strain A mice. Cancer Res. 33:3069-3085.
122. Stott, H., Stephens, R.J., Fox, W., and Roy, D.C. (1976). 5-Year follow-up of cytotoxic chemotherapy as an adjuvant to surgery in carcinoma of the bronchus. B. J. Cancer 34(2):167-173.
123. Suruda, A., Schulte, P., Boeniger, M., Hayes, R.B., Livingston, G.K., and Steenland, K. (1993). Cytogenetic effects of formaldehyde exposure in students of mortuary science. Cancer Epidemiol. Biomarkers Prev. 2:453-460.
124. Swenberg, J.A., Kerns, W.D., Mitchell, R.I., Gralla, E.J., and Pavkov, K.L. (1980). Induction of squamous cell carcinomas of the rat nasal cavity by inhalation exposure to formaldehyde vapor. Cancer Res. 40(9):3398-402.
125. Takahashi, M., Hasegawa, R., Furukawa, F., Toyoda, K., Sato, H., and Hayashi, Y. (1986). Effects of ethanol, potassium metabisulfite, formaldehyde and hydrogen peroxide on gastric carcinogenesis in rats after initiation with N-methyl-N′-nitrosoguanidine. Jpn. J. Cancer Res. 77:118-124.
126. Thomson, E.J., Shackleton, S., and Harrington, J.M. (1984). Chromosome aberrations and sister-chromatid exchange frequencies in pathology staff occupationally exposed to formaldehyde. Mutat. Res. 141:89-93.
127. Til, H.P., Woutersen, R.A., and Feron, V.J. (1988). Evaluation of the oral toxicity of acetaldehyde and formaldehyde in a 4-week drinking-water study in rats. Food Chem. Toxicol. 26:447-452.
128. Til, H.P., Woutersen, R.A., Feron, V.J., Hollanders, V.H., Falke, H.E., and Clary, J.J. (1989). Two-year drinking-water study of formaldehyde in rats. Food Chem. Toxicol. 27(2):77-87.
129. To, H., Ohdo, S., Shin, M., Uchimaru, H., Yukawa, E., Higuchi, S., Fuijimura, A., and Kobayashi, E. (2003). Dosing time dependency of doxorubicin-induced cardiotoxicity and bone marrow toxicity in rats. J. Pharm. Pharmacol. 55(6):803-810.
130. Tobe, M., Natio, K., and Kurokawa, Y. (1989). Chronic toxicity study on formaldehyde administered orally to rats. Toxicology 56:79-86.
131. Trainor, K.J., and Morley, A.A. (1976). Screening of cytotoxic drugs for residual bone marrow damage. J. Natl. Cancer Inst. 57(6):1237-1239.
132. Trainor, K.J., Seshadri, R.S., and Morley, A.A. (1979). Residual marrow injury following cytotoxic drugs. Leukocyle. Res. 3(4):205-210.
133. U.S. Environmental Protection Agency. (2005). Guidelines for Carcinogen Risk Assessment. Risk Assessment Forum, U.S. EPA, Washington, Dc. EPA/630/P-03/001B.
134. U.S. Environmental Protection Agency, National Center for Environmental Assessment. (1997). Chemical and Radiation Leukemogenesis in Humans and Rodents and the Value of Rodent Models for Assessing Risks of Lymphohematopoietic Cancers. ORD, U.S. EPA, EPA600R-97/090. Washington, DC.
135. U.S. Food and Drug Administration. (1998). Indirect food additives, adjuvants, production aids, and sanitizers. Fed. Reg. 63:35134-35135.
136. Valeriote, F.A., and Tolen, S.J. (1972). Survival of hematopoietic and lympha colony-forming cells in vivo following the administration of a variety of alkylating agents. Cancer Res. 32(3):470-476.
137. Van Putten, L.M., and Lelieveld, P. (1971). Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard. Eur. J. Cancer 7(1):11-16.
138. Vargova, M., Wagnerova, J., and Liskova, A. (1993). Subacute immunotoxicity study of formaldehyde in male rats. Drug Chem. Toxicol. 16:255-275.
139. Vasudeva, N., and Anand, C. (1996). Cytogenetic evaluation of medical students exposed to formaldehyde vapor in the gross anatomy dissection laboratory. J. Am. Coll. Health 44:177-179.
140. Walker and Bole. (1971). Augmented incidence of neoplasia in femaler New Zealand black/New Zealand white mice treated with long term cyclophosphamide. J. Lab. Clin. Med. 78:978-979.
141. Weisburger, E.K. (1977). Bioassay program for carcinogenic hazards of cancer chemotherapeutic agents. Cancer 40(4 Suppl.):1935-1949.
142. Woutersen, R.A., Appleman, L.M., and Wilmer, J.W. (1987). Subchronic (13-week) inhalation toxicity study of formaldehyde in rats. J. Appl. Toxicol. 7:43-49.
143. Yager, J.W., Cohn, K.L., Spear, R.C., Fisher, J.M., and Morse, L. (1986). Sister-chromatid exchanges in lymphocytes of anatomy students exposed to formaldehyde-embalming solution. Mutat. Res. 174:135-139.
144. Ying, C.J., Yan, W.S., Zhao, M.Y., Ye, X.L., Xie, H., and Yin, S.Y. (1997). Micronuclei in nasal mucosa, oral mucosa and lymphocytes in students exposed to formaldehyde vapor in anatomy class. Biomed. Environ. Sci. 10:451-455.
145. Ying, C.J., Ye, X.L., Xie, H., Yan, W.S., Zhao, M.Y., and Xia, T. (1999). Lymphocyte subsets and sister-chromatid exchanges in the students exposed to formaldehyde vapor. Biomed. Environ. Sci. 12:88-94.
146. Yoon, B.I., Hirabayashi, Y., Kawasaki, Y., Kodama, Y., Kaneko, T., Kim, D. Y., and Inoue, T. (2001). Mechanism of action of benzene toxicity: cell cycle suppression in hemopoietic progenitor cells (CFU-GM). Exp. Hematol. 29(3):278-285.